UK Bioindustry Association (BIA) launches new Genomics Advisory Committee at annual Committee Summit
The BIA has established the Genomics Advisory Committee to support the strategic objective that the UK starts, scales and builds world-leading genomic businesses. Companies and organisations represented on the Committee at its launch include Congenica, Eagle Genomics, Genomics plc, Global Gene Corp, LGC ltd, NewGene ltd, Oxford Nanopore Technologies ltd and the Wellcome Sanger Institute.
The Committee will act as a leadership platform for sharing and discussing issues of common concern between genomic businesses and will provide expert advice on important issues such as the use of data and embedding genomic medicine in the NHS. It has already got off to a flying start through supporting a panel on genomics that the BIA participated with alongside partners in San Francisco in January during the 36th annual JP Morgan Healthcare Conference.
“I am honoured to be the first Chair of this exciting new BIA Advisory Committee. Developments such as the 100,000 Genomes Project and research carried out by the Sanger Institute at the Wellcome Genome Campus in Hinxton Cambridge provide a solid foundation on which UK SMEs can build and grow. The BIA Genomics Advisory Committee will provide strength to the voice of this community.”
Dr Adrian Ibrahim Chair of the Genomics Advisory Committee and Head of Business Development and Technology Transfer in the Innovations team at the Wellcome Sanger Institute
“I’m delighted to launch the new BIA Genomics Advisory Committee. Genomic medicine is on the brink of transforming healthcare and the UK is at the forefront of this revolution. Convening this group will strengthen the voice of UK industry at an exciting and interesting time for genomics, working to ensure that the UK environment remains supportive and internationally competitive for genomic SMEs.”
BIA Chief Executive Steve Bates OBE
The Genomics Advisory Committee will be launched at the fourth annual BIA Committee Summit taking place today in London. Over 170 BIA members will gather to discuss key issues of importance to the UK bioscience sector.
The meeting of the Genomics Advisory Committee will take place alongside those of seven other Advisory Committees focussed on the respective issues of Cell and Gene Therapy, Engineering Biology, Finance and Tax, Intellectual Property, Manufacturing, Regulatory Affairs and Science and Innovation.
More information
Further information on the BIA Genomics Advisory Committee can be found at: https://www.bioindustry.org/bia-membership/advisory-committees/genomics-advisory-committee.html
Further information on all BIA Advisory Committees can be found at: https://www.bioindustry.org/bia-membership/advisory-committees.html
The full agenda for the 2018 BIA Committee Summit can be found at: https://www.bioindustry.org/event-listing/bia-committee-summit-2018.html
Selected websites
About the BIA
Established over 25 years ago at the infancy of biotechnology, the BioIndustry Association (BIA) is the trade association for innovative enterprises involved in UK bioscience. Members include emerging and more established bioscience companies; pharmaceutical companies; academic, research and philanthropic organisations; and service providers to the bioscience sector. The BIA represents the interests of its members to a broad section of stakeholders, from government and regulators to patient groups and the media. Our goal is to secure the UK’s position as a global hub and as the best location for innovative research and commercialisation, enabling our world-leading research base to deliver healthcare solutions that can truly make a difference to people’s lives. For further information, please go to www.bioindustry.org and twitter.com/BIA_UK
The Wellcome Sanger Institute
The Wellcome Sanger Institute is one of the world’s leading genome centres. Through its ability to conduct research at scale, it is able to engage in bold and long-term exploratory projects that are designed to influence and empower medical science globally. Institute research findings, generated through its own research programmes and through its leading role in international consortia, are being used to develop new diagnostics and treatments for human disease. To celebrate its 25th year in 2018, the Institute is sequencing 25 new genomes of species in the UK. Find out more at www.sanger.ac.uk or follow @sangerinstitute
Wellcome Genome Campus
The Wellcome Genome Campus is home to some of the world’s foremost Institutes and organisations in genomics and computational biology, committed to delivering life-changing science with the reach, scale and imagination to solve some of humanity’s greatest challenges: www.wellcomegenomecampus.org
